Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Polygenic risk scores (PRSs) have recently been used to inform reproductive decision-making in the context of embryonic screening. While this is yet to be widespread, it is contested and raises several challenges. This article provides an overview of some of the ethical considerations that arise with using PRSs for embryo screening and offers a series of regulatory considerations for jurisdictions that may wish to permit this in the future. These regulatory considerations cover possible regulators and regulatory tools, eligibility criteria, information and education requirements and the need for ongoing refinement of the relevant technology, research and consultation.

More information Original publication

DOI

10.1136/jme-2024-110145

Type

Journal article

Publication Date

2025-09-22T00:00:00+00:00

Volume

51

Pages

719 - 728

Total pages

9

Keywords

Ethics- Medical, Policy, Reproductive Medicine, Humans, Multifactorial Inheritance, Genetic Testing, Female, Risk Assessment, Preimplantation Diagnosis, Decision Making, Pregnancy, Genetic Predisposition to Disease, Genetic Risk Score